Sanofi-Aventis begins tender offer for Chattem
This article was originally published in Scrip
Sanofi-Aventis has commenced its €1.9 billion tender offer for the OTC and branded consumer product company Chattem. The tender offer is scheduled to expire at midnight on February 8th, unless the offer is extended. Following the close of the deal, Chattem will merge with Sanofi-Aventis's wholly owned subsidiary, River Acquisition.